Innovent Biopharmaceutical Transformation slide image

Innovent Biopharmaceutical Transformation

State-of-the-art Manufacturing Facilities Designed to, Built with, and Operating at International Standards R&D Labs Total capacity: 60,000 L 36,000L Administration Warehouse QC labs 24,000L A total of 60,000L manufacturing facilities in operation, providing competitive advantage on the production cost of products including TYVYTⓇ and other antibody drugs. More capacity is under construction. • Full CMC capability across process development, manufacturing, quality, supply chain and engineering, with talented management and Subject expert with MNC or Oversea experience. • Advanced CMC development capability including perfusion, ADC and high concentration DP platform End-to-end quality system across product lifecycle per international GMP requirements Established world-class CMC Strategic Advisory Board with Strong Support from Global Renowned Top Experts Innovent • • • David LaPré, MBA. Erwin Vanhaecke, Ph.D. An accomplished biopharmaceutical executive Former EVP/Head of Global Pharma Technical Operations Former VP of Global Supply Chain Management in Roche Currently President of DGL Advisors, LLC Holder of a BS degree from Worcester Polytechnic Institute in Worcester, Massachusetts and an MBA from New York University Former Head of Group Quality for Novartis Former SVP of Global Quality Operations Former Chairman of the Ophthalmic Special Interest Group Currently President of Vanhaecke and Associates Winner of Novartis Excellence Award, Albert Nelson Marquis Lifetime Achievement Award and the Cross of Knight in the Order of the Crown (Belgium) Confidential Copyright©2022 Innovent Chiang Syin, Ph.D. Former Chief Quality Officer and SVP of WuXi Biologics Former FDA Associate Country Director Currently President and founder of Meadows Biosolutions, LLC. Over 30 years of experiences working in the regulatory agencies and biotech industry Winner of Foreign Services Award, Scientific Achievement Award, Public Health Achievement, and Outstanding Service Award from FDA • • Charles L. Cooney, Ph.D. Full professor of the Massachusetts Institute of Technology Director of Green Light Bioscience, Mitra Biotech, Mitra RxDx and LayerBio, etc. Adviser to the Singapore MIT Alliance for Research and Technology (SMART) Innovation Center Founding Faculty Director of the Deshpande Center for Technological Innovation at MIT 31
View entire presentation